(Q35995627)

English

Pre- and post-synaptic cortical cholinergic deficits are proportional to amyloid plaque presence and density at preclinical stages of Alzheimer's disease

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

Pre- and post-synaptic cortical cholinergic deficits are proportional to amyloid plaque presence and density at preclinical stages of Alzheimer's disease (English)

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

Alzheimer's disease

0 references

7

object named as

Thomas G Beach

1 reference

Europe PubMed Central

11 August 2017

PMC publication ID

author name string

Pamela E Potter

1

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

Paula K Rauschkolb

2

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

Yoga Pandya

3

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

Lucia I Sue

4

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

Marwan N Sabbagh

5

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

Douglas G Walker

6

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

1 May 2011

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

Acta Neuropathologica

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

122

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

1

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

49-60

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

Cortical M1 receptor concentration increases without a concomitant change in function in Alzheimer's disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3362487

2 October 2017

Deletion of M1 muscarinic acetylcholine receptors increases amyloid pathology in vitro and in vivo

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3362487

2 October 2017

Basal cerebral metabolism may modulate the cognitive effects of Abeta in mild cognitive impairment: an example of brain reserve.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3362487

2 October 2017

Increased matrix metalloproteinase 9 activity in mild cognitive impairment

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3362487

2 October 2017

Donepezil delays progression to AD in MCI subjects with depressive symptoms

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3362487

2 October 2017

Cortical alpha7 nicotinic acetylcholine receptor and beta-amyloid levels in early Alzheimer disease.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3362487

2 October 2017

Rivastigmine for Alzheimer's disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3362487

2 October 2017

Fibrillar amyloid-beta burden in cognitively normal people at 3 levels of genetic risk for Alzheimer's disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3362487

2 October 2017

Episodic memory loss is related to hippocampal-mediated beta-amyloid deposition in elderly subjects

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3362487

2 October 2017

Cholinergic treatments with emphasis on m1 muscarinic agonists as potential disease-modifying agents for Alzheimer's disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3362487

2 October 2017

The Sun Health Research Institute Brain Donation Program: description and experience, 1987-2007

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3362487

2 October 2017

Acetylcholine receptors in dementia and mild cognitive impairment.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3362487

2 October 2017

Longitudinal MRI findings from the vitamin E and donepezil treatment study for MCI.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3362487

2 October 2017

What constitutes clinical evidence for neuroprotection in Alzheimer disease: support for the cholinesterase inhibitors?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3362487

2 October 2017

Neuropathologic features of amnestic mild cognitive impairment

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3362487

2 October 2017

Cognitive performance in patients with Alzheimer's disease receiving cholinesterase inhibitors for up to 5 years

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3362487

2 October 2017

Vitamin E and donepezil for the treatment of mild cognitive impairment

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3362487

2 October 2017

A randomised placebo controlled study to assess the effects of cholinergic treatment on muscarinic receptors in Alzheimer's disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3362487

2 October 2017

Stable beta-secretase activity and presynaptic cholinergic markers during progressive central nervous system amyloidogenesis in Tg2576 mice

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3362487

2 October 2017

PET studies and cholinergic therapy in Alzheimer's disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3362487

2 October 2017

Cognitive changes and modified processing of amyloid precursor protein in the cortical and hippocampal system after cholinergic synapse loss and muscarinic receptor activation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3362487

2 October 2017

Quantitation of amyloid beta-protein (A beta) in the cortex during aging and in Alzheimer's disease.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3362487

2 October 2017

Neurochemical studies of Alzheimer's disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3362487

2 October 2017

Regulation of APP processing. Potential for the therapeutical reduction of brain amyloid burden

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3362487

2 October 2017

Anterograde vs. retrograde degeneration of the nucleus basalis medialis in Alzheimer's disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3362487

2 October 2017

Clinical, pathological, and neurochemical changes in dementia: A subgroup with preserved mental status and numerous neocortical plaques

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3362487

2 October 2017

Inhibition of high affinity choline transport attenuates both cholinergic and non-cholinergic effects of ethylcholine aziridinium (AF64A).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3362487

2 October 2017

The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3362487

2 October 2017

Neuropathological stageing of Alzheimer-related changes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3362487

2 October 2017

Cholinergic agonists and interleukin 1 regulate processing and secretion of the Alzheimer beta/A4 amyloid protein precursor

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3362487

2 October 2017

Identification of normal and pathological aging in prospectively studied nondemented elderly humans

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3362487

2 October 2017

Mild cognitive impairment in the elderly is associated with volume loss of the cholinergic basal forebrain region

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3362487

11 July 2018

Loss of calbindin-D28K from aging human cholinergic basal forebrain: relation to plaques and tangles

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3362487

11 July 2018

Loss of basal forebrain P75(NTR) immunoreactivity in subjects with mild cognitive impairment and Alzheimer's disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3362487

11 July 2018

Survival and plasticity of basal forebrain cholinergic systems in mice transgenic for presenilin-1 and amyloid precursor protein mutant genes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3362487

11 July 2018

Treatment with the selective muscarinic agonist talsaclidine decreases cerebrospinal fluid levels of total amyloid beta-peptide in patients with Alzheimer's disease.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3362487

11 July 2018

Evolution of Alzheimer's disease-related cytoskeletal changes in the basal nucleus of Meynert.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3362487

11 July 2018

Cholinergic deafferentation of the rabbit cortex: a new animal model of Abeta deposition

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3362487

11 July 2018

The effect of sequential lesioning in the basal forebrain on cerebral cortical glucose metabolism in rats. An animal positron emission tomography study.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3362487

11 July 2018

Preservation of nucleus basalis neurons containing choline acetyltransferase and the vesicular acetylcholine transporter in the elderly with mild cognitive impairment and early Alzheimer's disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3362487

11 July 2018

Attenuation of muscarinic receptor-G-protein interaction in Alzheimer disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3362487

11 July 2018

Aging, Alzheimer's disease, and the cholinergic system of the basal forebrain

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3362487

11 July 2018

Neurochemical activities in human temporal lobe related to aging and Alzheimer-type changes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3362487

11 July 2018

Radiochemical micro assays for the determination of choline acetyltransferase and acetylcholinesterase activities

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3362487

11 July 2018

Reduced number of [3H]nicotine and [3H]acetylcholine binding sites in the frontal cortex of Alzheimer brains

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3362487

11 July 2018

A4 amyloid protein deposition and the diagnosis of Alzheimer's disease: prevalence in aged brains determined by immunocytochemistry compared with conventional neuropathologic techniques.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3362487

11 July 2018

Nicotinic receptor abnormalities in Alzheimer's and Parkinson's diseases

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3362487

11 July 2018

Convergent cholinergic activities in aging and Alzheimer's disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3362487

11 July 2018

Persistent innervation of the rat neocortex by basal forebrain cholinergic neurons despite the massive reduction of cortical target neurons. I. Morphometric analysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3362487

11 July 2018

Cholinergic fibre loss associated with diffuse plaques in the non-demented elderly: the preclinical stage of Alzheimer's disease?

1 reference

https://api.crossref.org/works/10.1007%2FS00401-011-0831-1

21 January 2018

The cholinergic deficit coincides with Abeta deposition at the earliest histopathologic stages of Alzheimer disease.

1 reference

https://api.crossref.org/works/10.1007%2FS00401-011-0831-1

21 January 2018

Reduction of cerebrospinal fluid amyloid beta after systemic administration of M1 muscarinic agonists

1 reference

https://api.crossref.org/works/10.1007%2FS00401-011-0831-1

21 January 2018

Neuropathological indexes of Alzheimer's disease in demented and nondemented persons aged 80 years and older

1 reference

https://api.crossref.org/works/10.1007%2FS00401-011-0831-1

21 January 2018

Choline acetyltransferase activity and histopathology of frontal neocortex from biopsies of demented patients.

1 reference

https://api.crossref.org/works/10.1007%2FS00401-011-0831-1

21 January 2018

Xanomeline compared to other muscarinic agents on stimulation of phosphoinositide hydrolysis in vivo and other cholinomimetic effects.

1 reference

https://api.crossref.org/works/10.1007%2FS00401-011-0831-1

21 January 2018

Cholinergic markers in elderly patients with early signs of Alzheimer disease

1 reference

https://api.crossref.org/works/10.1007%2FS00401-011-0831-1

21 January 2018

Upregulation of choline acetyltransferase activity in hippocampus and frontal cortex of elderly subjects with mild cognitive impairment.

1 reference

https://api.crossref.org/works/10.1007%2FS00401-011-0831-1

21 January 2018

Phosphoinositide hydrolysis, G alpha q, phospholipase C, and protein kinase C in post mortem human brain: effects of post mortem interval, subject age, and Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1007%2FS00401-011-0831-1

21 January 2018

Superior frontal cortex cholinergic axon density in mild cognitive impairment and early Alzheimer disease.

1 reference

https://api.crossref.org/works/10.1007%2FS00401-011-0831-1

21 January 2018

Neuropathologic outcome of mild cognitive impairment following progression to clinical dementia

1 reference

https://api.crossref.org/works/10.1007%2FS00401-011-0831-1

21 January 2018

Relationship between Alzheimer's disease clinical stage and Gq/11 in subcellular fractions of frontal cortex.

1 reference

https://api.crossref.org/works/10.1007%2FS00401-011-0831-1

21 January 2018

Randomized, Placebo-Controlled Trial of the Effects of Donepezil on Neuronal Markers and Hippocampal Volumes in Alzheimer’s Disease

1 reference

https://api.crossref.org/works/10.1007%2FS00401-011-0831-1

21 January 2018

In vivo SPECT imaging of vesicular acetylcholine transporter using [(123)I]-IBVM in early Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1007%2FS00401-011-0831-1

21 January 2018

Loss of nucleus basalis neurons containing trkA immunoreactivity in individuals with mild cognitive impairment and early Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1007%2FS00401-011-0831-1

21 January 2018

Differences in regional and subcellular localization of G(q/11) and RGS4 protein levels in Alzheimer's disease: correlation with muscarinic M1 receptor binding parameters

1 reference

https://api.crossref.org/works/10.1007%2FS00401-011-0831-1

21 January 2018

Beta-amyloid imaging and memory in non-demented individuals: evidence for preclinical Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1007%2FS00401-011-0831-1

21 January 2018

Pathologic and nicotinic receptor binding differences between mild cognitive impairment, Alzheimer disease, and normal aging

1 reference

https://api.crossref.org/works/10.1007%2FS00401-011-0831-1

21 January 2018

Cortico-hippocampal APP and NGF levels are dynamically altered by cholinergic muscarinic antagonist or M1 agonist treatment in normal mice

1 reference

https://api.crossref.org/works/10.1007%2FS00401-011-0831-1

21 January 2018

Decrease in GTP-sensitive high affinity agonist binding of muscarinic acetylcholine receptors in autopsied brains of dementia with Lewy bodies and Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1007%2FS00401-011-0831-1

21 January 2018

The decline in synapses and cholinergic activity is asynchronous in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1007%2FS00401-011-0831-1

21 January 2018

Impaired coupling of muscarinic M1 receptors to G-proteins in the neocortex is associated with severity of dementia in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1007%2FS00401-011-0831-1

21 January 2018

Disrupted muscarinic M1 receptor signaling correlates with loss of protein kinase C activity and glutamatergic deficit in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1007%2FS00401-011-0831-1

21 January 2018

The selective muscarinic M1 agonist AF102B decreases levels of total Abeta in cerebrospinal fluid of patients with Alzheimer's disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3362487

23 September 2018

Reorganization of cholinergic terminals in the cerebral cortex and hippocampus in transgenic mice carrying mutated presenilin-1 and amyloid precursor protein transgenes.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3362487

23 September 2018

Effects of damage to the basal forebrain on brain glucose utilization: a reevaluation using positron emission tomography in baboons with extensive unilateral excitotoxic lesion

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3362487

23 September 2018

Alteration of phospholipase C-delta protein level and specific activity in Alzheimer's disease.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3362487

23 September 2018

Cortical cholinergic fibers in aging and Alzheimer's disease: a morphometric study

1 reference

https://pubmed.ncbi.nlm.nih.gov/21533854

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Isolation of hippocampal synaptosomes on Percoll gradients: cholinergic markers and ligand binding sites

1 reference

https://pubmed.ncbi.nlm.nih.gov/21533854

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Regulated secretion of beta-amyloid precursor protein in rat brain

1 reference

https://pubmed.ncbi.nlm.nih.gov/21533854

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Consensus recommendations for the postmortem diagnosis of Alzheimer's disease. The National Institute on Aging, and Reagan Institute Working Group on Diagnostic Criteria for the Neuropathological Assessment of Alzheimer's Disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/21533854

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

[11C]PIB in a nondemented population: Potential antecedent marker of Alzheimer disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/21533854

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Plasma levels of Abeta42 and Abeta40 in Alzheimer patients during treatment with the acetylcholinesterase inhibitor tacrine

1 reference

https://pubmed.ncbi.nlm.nih.gov/21533854

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinico-pathologic studies in dementia: nondemented subjects with pathologically confirmed Alzheimer's disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/21533854

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI

1 reference

https://pubmed.ncbi.nlm.nih.gov/21533854

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S00401-011-0831-1

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q35995627&oldid=2198047802"